slotkoers
Korea S.E.
00:00:00 29-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
18.990
KRW
|
-1,09%
|
|
-3,90%
|
-19,70%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
128.464
|
110.323
|
111.130
|
99.170
|
125.151
|
164.817
|
Bedrijfswaarde
1 |
74.549
|
58.483
|
66.326
|
35.265
|
-174.506
|
-70.366
|
K/w-verhouding
|
43,6
x
|
16,9
x
|
39,4
x
|
-82,8
x
|
1,2
x
|
-7,9
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
2,08
x
|
2,28
x
|
2,74
x
|
2,36
x
|
2,04
x
|
2,11
x
|
Bedrijfswaarde/omzet
|
1,21
x
|
1,21
x
|
1,63
x
|
0,84
x
|
-2,85
x
|
-0,9
x
|
Bedrijfswaarde/EBITDA
|
14,1
x
|
32
x
|
59,7
x
|
27,6
x
|
-39,7
x
|
14,3
x
|
Bedrijfswaarde/FCF
|
4,65
x
|
6,88
x
|
-28,6
x
|
-7,82
x
|
-1,29
x
|
6,31
x
|
FCF Yield
|
21,5%
|
14,5%
|
-3,49%
|
-12,8%
|
-77,5%
|
15,9%
|
Price to Book
|
0,4
x
|
0,36
x
|
0,37
x
|
0,33
x
|
0,28
x
|
0,42
x
|
Aantal aandelen (in duizenden)
|
6.719
|
6.719
|
6.719
|
6.719
|
7.414
|
6.969
|
Referentieprijs
2 |
19.120
|
16.420
|
16.540
|
14.760
|
16.880
|
23.650
|
Datum van publicatie
|
01-03-19
|
29-02-20
|
01-03-21
|
01-03-22
|
01-03-23
|
29-02-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
61.653
|
48.412
|
40.601
|
42.090
|
61.248
|
78.053
|
EBITDA
1 |
5.272
|
1.828
|
1.111
|
1.276
|
4.391
|
-4.907
|
Bedrijfsresultaat (EBIT)
1 |
2.258
|
-1.257
|
-1.948
|
-1.797
|
1.297
|
-7.993
|
Operationele Marge
|
3,66%
|
-2,6%
|
-4,8%
|
-4,27%
|
2,12%
|
-10,24%
|
Resultaat voor belastingen (EBT)
1 |
4.587
|
9.179
|
4.417
|
-1.523
|
137.973
|
-21.345
|
Nettowinst (verlies)
1 |
2.946
|
6.719
|
3.220
|
-1.368
|
105.241
|
-20.941
|
Nettomarge
|
4,78%
|
13,88%
|
7,93%
|
-3,25%
|
171,83%
|
-26,83%
|
WPA
2 |
438,4
|
971,7
|
419,9
|
-178,3
|
14.104
|
-2.994
|
Free Cash Flow
1 |
16.019
|
8.499
|
-2.317
|
-4.509
|
135.215
|
-11.160
|
FCF-marge
|
25,98%
|
17,56%
|
-5,71%
|
-10,71%
|
220,77%
|
-14,3%
|
Kasstroomconversie (ebitda)
|
303,87%
|
465%
|
-
|
-
|
3.079,15%
|
-
|
Kasstroomconversie (nettowinst)
|
543,85%
|
126,5%
|
-
|
-
|
128,48%
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
01-03-19
|
29-02-20
|
01-03-21
|
01-03-22
|
01-03-23
|
29-02-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
53.916
|
51.840
|
44.804
|
63.905
|
299.657
|
235.182
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
16.019
|
8.499
|
-2.317
|
-4.509
|
135.215
|
-11.160
|
ROE (netto-inkomsten/eigen vermogen)
|
0,91%
|
2,01%
|
0,93%
|
-0,39%
|
26,6%
|
-5,04%
|
ROA (netto-inkomsten/totale activa)
|
0,41%
|
-0,22%
|
-0,33%
|
-0,3%
|
0,19%
|
-1,09%
|
Totale activa
1 |
724.964
|
-3.065.032
|
-979.994
|
452.069
|
56.218.584
|
1.924.007
|
Nettoactief per aandeel
2 |
48.272
|
45.051
|
45.310
|
45.106
|
60.097
|
56.158
|
Cashflow per aandeel
2 |
207,0
|
4.861
|
4.723
|
6.630
|
36.811
|
23.488
|
Capex
1 |
1.209
|
1.240
|
4.817
|
10.930
|
62.011
|
7.727
|
Capex/omzet
|
1,96%
|
2,56%
|
11,87%
|
25,97%
|
101,25%
|
9,9%
|
Datum van publicatie
|
01-03-19
|
29-02-20
|
01-03-21
|
01-03-22
|
01-03-23
|
29-02-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -19,70% | 96,66 mln. | | +15,85% | 42,57 mld. | | +18,28% | 21,01 mld. | | +16,48% | 14,86 mld. | | +17,68% | 14,47 mld. | | +48,57% | 12,61 mld. | | -0,05% | 6,79 mld. | | -12,56% | 6,57 mld. | | +14,28% | 5,62 mld. | | +6,11% | 4,66 mld. |
Generieke geneesmiddelen
|